Back to Search
ROBERT BUCHANAN, CDCA
CDCA
Addiction (Substance Use Disorder) Counselor
NPI: 1336003425Individual
Specialties, Licenses & Credentials
Addiction (Substance Use Disorder) CounselorPrimary
Counselor — Addiction (Substance Use Disorder)
Code: 101YA0400X
CDCA.194564(OH)
Clinical Trials (3)
3
Linked Trials
0
Recruiting
3
With Results
Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
NCT00176423COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
NCT00056498COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia
NCT00492336COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (3)
Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.
PMID 25368372·Schizophr Bull·2015
2-rct
Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine.
PMID 20664583·Neuropsychopharmacology·2010
4-observational
Galantamine for the treatment of cognitive impairments in people with schizophrenia.
PMID 17986678·Am J Psychiatry·2008
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1724 S 3RD ST
IRONTON, OH 45638 - Phone
- (740) 442-7143
Quick Facts
- NPI
- 1336003425
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 3
Are you this provider?
Claim Your Profile